Cervical cancer is one of the most common gynecologic cancer, and endocervical curettage (ECC) and endocervical brush (ECB) can be used in the diagnosis of cervical cancer. In this study, it was aimed to investigate the agreement between two methods and evaluate whether more invasive ECC may be replaced with ECB. The data of obstetric patients who were admitted to the Gynecology and Obstetrics Clinic of a tertiary health care center in 2016 were retrospectively reviewed. A total of 170 patients were referred for colposcopy due to abnormal Papanicolaou test (Pap smear) results and / or high-risk human papilloma virus (HPV) positivity. All patients were examined without anesthesia through colposcopically directed biopsies and underwent cervical sampling with ECC and ECB. The ECB and ECC samples were grouped as negative, low-grade, and high-grade. ECB was negative in 132 (83.5%) of 158 patients with negative ECC results. Four patients with low-grade ECC results also had low-grade ECB results (100%). Of 8 patients with high-grade ECC results, only 4 patients (50%) had high-grade ECB results. Regarding all the data, a moderate degree of agreement was found between the two methods with an intraclass correlation coefficient of 0.503 (95% CI: [0.327-0.633], p
___
1. Richardson DL. Cervical cancer. In: Hoffman BL et al. Williams Gynecology (3rd ed) 2016; 657- 679.
2. Undurraga M, Catarino R, Navarria I, et al. User perception of endocervical sampling: A randomized comparison of endocervical evaluation with the curette vs. cytobrush. PLoS One 2017; 12: e0186812.
3. Gultekin M, Kucukyildiz I, Karaca MZ, et al. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia? Int J Gynecol Cancer 2017; 27: 1525-1533.
4. Kim HS, Park JS, Park JY, et al. Comparison of two preparation methods for endocervical evaluation. Acta Cytol 2007; 51: 742-748.
5. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012; 137: 516-542.
6. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007; 90: 1-636.
7. Hoffman MS, Sterghos S Jr, Gordy LW, Gunasekaran S, Cavanagh D. Evaluation of the cervical canal with the endocervical brush. Obstet Gynecol 1993; 82: 573-577.
8. Weitzman GA, Korhonen MO, Reeves KO, Irwin JF, Carter TS, Kaufman RH. Endocervical brush cytology. An alternative to endocervical curettage? J Reprod Med 1988; 33: 677-683.
9. Andersen W, Frierson H, Barber S, Tabbarah S, Taylor P, Underwood P. Sensitivity and specificity of endocervical curettage and the endocervical brush for the evaluation of the endocervical canal. Am J Obstet Gynecol 1988; 159: 702-707.
10. Dunn TS, Stevens-Simon C, Moeller LD, Miekle S. Comparing endocervical curettage and endocervical brush at colposcopy. J Low Genit Tract Dis 2000; 4: 76-78.
11. Martin D, Umpierre SA, Villamarzo G, et al. Comparison of the endocervical brush and the endocervical curettage for the evaluation of the endocervical canal. P R Health Sci J 1995; 14: 195- 197.
12. Paraiso MF, Brady K, Helmchen R, Roat TW. Evaluation of the endocervical Cytobrush and Cervex-Brush in pregnant women. Obstet Gynecol 1994; 84: 539-543.
13. Nayar R, Wilbur DC. The Pap test and Bethesda 2014. Cancer Cytopathol 2015; 123: 271-281.
14. Werner CL. Preinvasive Lesions of the Lower Genital Tract. In: Hoffman BL et al. Williams Gynecology (3rd ed) 2016; 624-657.
15. Mogensen ST, Bak M, Dueholm M, et al. Cytobrush and endocervical curettage in the diagnosis of dysplasia and malignancy of the uterine cervix. Acta Obstet Gynecol Scand 1997; 76: 69-73.
16. Doo DW, Stickrath EH, Mazzoni SE, Alston MJ. Lack of Agreement Between Endocervical Brush and Endocervical Curettage in Women Undergoing Repeat Endocervical Sampling. J Low Genit Tract Dis 2016; 20: 296-299.